Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Immuno-Oncology Webinar: Immunotherapy Cancer Combinations – When, Who and at What Price?

This article was originally published in Scrip

Executive Summary

Immuno-oncology may be seen as the future of cancer therapy, but it is combination therapy that is the future of immuno-oncology. The potential to use different types of these novel immune-acting products together to boost cancer control is as exciting in its potential as it is mind-boggling in its complexity. In this third Immuno-Oncology Webinar in Informa's series, our team of experts use exclusive data and insight to delve into the world of combination cancer immunotherapies.